Onsolis


Indications and Reactions:

Role Indications Reactions
Primary
Cancer Pain 75.4%
Breakthrough Pain 7.6%
Pain 5.1%
Bladder Cancer 2.5%
Neoplasm Malignant 1.7%
Thrombosis Prophylaxis 1.7%
Analgesic Therapy 0.8%
Arthralgia 0.8%
Bone Neoplasm Malignant 0.8%
Bone Pain 0.8%
Fibromyalgia 0.8%
Migraine 0.8%
Product Used For Unknown Indication 0.8%
Death 20.0%
Intercepted Drug Dispensing Error 17.1%
Malignant Neoplasm Progression 14.3%
Intercepted Medication Error 12.4%
Incorrect Dose Administered 5.7%
Neoplasm Progression 3.8%
No Adverse Event 3.8%
Pancreatic Carcinoma 3.8%
Disease Progression 1.9%
Inappropriate Schedule Of Drug Administration 1.9%
Nausea 1.9%
Neutropenia 1.9%
Pain 1.9%
Paralysis 1.9%
Urinary Incontinence 1.9%
Vomiting 1.9%
Bladder Operation 1.0%
Cholelithiasis 1.0%
Deep Vein Thrombosis 1.0%
Dehydration 1.0%
Secondary
Cancer Pain 71.0%
Thrombosis Prophylaxis 12.9%
Bladder Cancer 9.7%
Breakthrough Pain 6.5%
Death 33.3%
Renal Cancer Metastatic 12.5%
Subdural Haematoma 8.3%
Vomiting 8.3%
Disease Progression 4.2%
Incorrect Dose Administered 4.2%
Malignant Melanoma 4.2%
Neoplasm Progression 4.2%
Pain 4.2%
Pruritus Generalised 4.2%
Radiation Injury 4.2%
Spinal Fracture 4.2%
Treatment Noncompliance 4.2%
Concomitant
Osteoporosis 100.0%
Osteonecrosis 100.0%

Drug Data